Navigation Links
Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
Date:5/22/2012

l employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim's endeavors.

In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.

For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.

More information on Boehringer Ingelheim's COPD portfolio
http://www.boehringer-ingelheim.com/products/prescription_medicines/chronic_obstructivepulmonarydisease.html


'/>"/>
SOURCE Boehringer Ingelheim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
2. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
3. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
4. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
5. Phase 2b Study of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)
6. Boehringer Ingelheim and Lillys new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
7. Boehringer Ingelheim and Xencor Enter a Collaboration Agreement for the Development, Manufacture, and Supply of Biosuperior Monoclonal Antibodies
8. CompleGen Announces Successful Delivery of Its XenoGene™ Technology to Boehringer Ingelheim for Drug Discovery Under a Non-Exclusive Agreement.
9. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
10. Boehringer Ingelheim Invests More Than $350 Million in 2011 U.S. Expansion Projects
11. Positive Interim Results from Interferon-Free Phase 2b SOUND-C2 Study with Boehringer Ingelheims Two Investigational HCV Direct Acting Antivirals Presented at AASLD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... , Sept. 12, 2014 /PRNewswire-iReach/ -- 9 th ... 22-24, 2014 – Bethesda, MD ... http://www.fdanews.com/9thInspectionsSummitEarlyBird   Photo - http://photos.prnewswire.com/prnh/20140912/145652 ... for the next inspection than to get a glimpse ... during and after an inspection. Come to ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 ... addition of the "Global Medical Technologies Market ... Medical technology is a collective term for ... used to ensure good health. The Global Medical ... anaesthetic and respiratory technology, In vitro diagnostics technology, ...
(Date:9/12/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ... results from a health economic analysis suggesting that use ... in a significant reduction in direct medical costs and ... side effects of unnecessary treatment.  "By ... conventional measures, as demonstrated in this analysis, the Oncotype ...
Breaking Medicine Technology:FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 2FDAnews Announces: Early Bird Registration Discount Ends Sept.19 for 9th Annual Inspections Summit, Oct. 22-24, 2014 3Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 2Global Medical Technologies Market 2014-2018: Key Vendors are GE, Johnson & Johnson, Medtronic, Roche and Siemens 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 2Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 3Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 4Genomic Health Announces Publication of Colon Cancer Cost-Effectiveness Study in PharmacoEconomics 5
(Date:9/14/2014)... each night may mean you,re less likely to take time off ... study included more than 3,700 people in Finland, aged 30 to ... Those who slept less than six hours or more than nine ... from work due to illness, the investigators found. People with the ... were those who slept between seven and eight hours a night. ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information for worldwide ... the site has announced that Arvixe ( http://www.arvixe.com/6883.html ... Hosting suppliers in the current market. , Arvixe ... provider, and the company’s reputation for reliability remains ... for its flexible hosting packages, decent uptime record ...
(Date:9/14/2014)... (PRWEB) September 14, 2014 A new DePuy ... Schulte LLC on behalf of a Franklin County, Ohio ... hip implant. The metal-on-metal hip lawsuit filed against Johnson ... the Ohio man was 40 years old when the Pinnacle ... No. 3:14-cv-02428-K) According to the hip implant lawsuit ...
(Date:9/14/2014)... Washington (PRWEB) September 14, 2014 School requires ... Washington law requires that they be screened only for far ... at twenty feet away. When their eyes do not ... their books, they will, at best, avoid reading; at ... brains and their ability to learn. Children who cannot ...
(Date:9/13/2014)... Recently, an experienced supplier of wedding dresses ... new collection of eggplant evening dresses . At ... rates, up to 58% off. According to the company’s ... 23. , The company’s new items are available ... plus size, modest, sexy outfits and so on. iFitDress.com ...
Breaking Medicine News(10 mins):Health News:A Good Night's Sleep May Mean a Good Day's Work 2Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 2Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 3Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 4Health News:Wright & Schulte LLC Files Another DePuy Pinnacle Hip Lawsuit Purporteding Risky Revision Surgery Needed Due To Failure of Metal-on-Metal Hip Replacement 5Health News:Cheap Eggplant Evening Dresses Now Announced By Experienced Company iFitDress.com 2
... Safety Technology, HONOLULU, Aug. 5 ... Medical Center will equip 100 additional medical-surgical,floor ... Systems,(LifeBed), bringing the total number LifeBed,s available ... any bed into a LifeBed, which,invisibly tracks ...
... - Her Son May Need a Liver ... Transplant, ... come true. As she heads to the Mrs.,America* competition in Tucson, Arizona on ... her 10-year-old son, Connor will be,healthy again. Connor was born with a deadly ...
... Communication, Training and Disaster ... Preparedness ... a leading IP solutions provider offering telepresence and VoIP,services to business ... by St. Vincent Catholic Medical,Centers of New York for a variety ...
... First Half of 2008 Over 2007, WEST PALM ... MDF ), a leading provider of healthcare,services in ... quarter ended June 30, 2008., On July 28, ... ended,June 30, 2008, the company,s Medicare Advantage HMO and ...
... (NYSE: SCR ), a leading manufacturer and supplier ... biotech,product Endu in China, today reported unaudited financial results ... -- Total revenue increased to RMB436.2 million (US$63.6 ... representing a 30.4% year-over-year growth;, -- Net income ...
... $72 ... Million ... System Building Strong Market Momentum, ST. LOUIS, Aug. 5 Stereotaxis, Inc. ... for the recent second quarter increased 36% to $10.7,million compared with $7.8 million ...
Cached Medicine News:Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 2Health News:Hoana Medical Expands Partnership With The Queen's Medical Center to Improve Patient Safety 3Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 2Health News:Mrs. California Uses Her Title to Save Lives - She Now Heads to Mrs. America Competition 3Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 2Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 3Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 2Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 3Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 4Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 5Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 6Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 7Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 8Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 9Health News:Metropolitan Health Networks Reports 2008 Second Quarter Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 2Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 3Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 4Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 5Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 6Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 7Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 8Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 9Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 10Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 11Health News:Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results 12Health News:Stereotaxis Reports Record Second Quarter Revenue 2Health News:Stereotaxis Reports Record Second Quarter Revenue 3Health News:Stereotaxis Reports Record Second Quarter Revenue 4Health News:Stereotaxis Reports Record Second Quarter Revenue 5Health News:Stereotaxis Reports Record Second Quarter Revenue 6Health News:Stereotaxis Reports Record Second Quarter Revenue 7Health News:Stereotaxis Reports Record Second Quarter Revenue 8
...
EDM Lumbar Drainage Kit with and without Bioglide are fabricated of radiopaque (barium impregnated) silicone tubing, and are packaged with stainless steel stylets inserted in the lumen....
... external ventricular drainage set (EVD ... fluid for external ventricular drainage. ... combination with a ventricular catheter ... 3XL probe from the Aesculap ...
... Bactiseal EVD Catheter system is ... catheter for external CSF drainage ... on catheter tube surfaces. Treated ... Impregnation Process, it reduces the ...
Medicine Products: